Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06763081

Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

Sponsor: University of Manitoba

View on ClinicalTrials.gov

Summary

The purpose of this study is to identify and validate a panel of genetic markers associated with selective serotonin reuptake inhibitors (SSRI)-induced behavioural activation in children and youth with major depressive disorder (MDD), anxiety disorders, or obsessive-compulsive disorder (OCD) that could be used clinically to reduce the incidence of this adverse event and improve health outcomes.

Official title: Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation in Children and Youth (PGx-SImBA)

Key Details

Gender

All

Age Range

6 Years - 24 Years

Study Type

OBSERVATIONAL

Enrollment

160

Start Date

2025-03-01

Completion Date

2030-12-31

Last Updated

2025-09-08

Healthy Volunteers

No

Interventions

OTHER

Not applicable- observational study

It's an observational study. Participants are not assigned an intervention as part of the study.

Locations (2)

Shared Health Facilities

Winnipeg, Manitoba, Canada

University of Manitoba College of Pharmacy

Winnipeg, Manitoba, Canada